---
$id: https://graph.org.ai/products/commodity/51152064
$type: Product
source: UNSPSC
code: "51152064"
title: "Orphenadrine citrate"
class: "51152000"
classTitle: "Neuromuscular blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Orphenadrine citrate

**UNSPSC Code**: 51152064
**Class**: [Neuromuscular blocking agents](Neuromuscular blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a muscle relaxant with the molecular formula C18H23NO.C6H8O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X0A40N8I4S, chemically known as n,n-dimethyl-2-(o-methyl-.alpha.-phenylbenzyloxy)ethylamine hydrochloride but more generally known as orphenadrine citrate, which bears US NIH Compound Identifier 4601. European Medicines Agency schedules Orphenadrine citrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03546MIG. Most nations, for tariff and trade purposes, schedule orphenadrine citrate under HS 29221990 and SITC 51461. As of Q4 2014, ORPHENADRINE CITRATE remains US FDA's Preferred Term for this commodity. Orphenadrine citrate bears US NLM identifiers UMLS ID C0029310 and NCI Concept Code C47641. SMILES: CC1CCCCC1C(C2CCCCC2)OCCN(C)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.

